Salbiya, Balma .
HRN: 20-39-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/19/2023
04/25/2023
IVTT
500MG
TID
Intestinal Amebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes